Skip to main content
Figure 4 | BMC Cancer

Figure 4

From: Statistical techniques to construct assays for identifying likely responders to a treatment under evaluation from cell line genomic data

Figure 4

Kaplan-Meier plots: survival rates of patients classified as dacetuzumab sensitive, semi-sensitive, and resistant by each of our classifiers. Blue curves indicate dacetuzumab sensitive patients, green curves semi-sensitive, and red curves resistant. We omit two classifiers that involved no genes and hence classified all patients with the same dacetuzumab sensitivity.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us